Holen Sie sich die Stockscreener-App
1.19
4.03%
-0.05
Handel nachbörslich:
1.19
Dermata Therapeutics Inc Aktie (DRMA) Neueste Nachrichten
Dermata Therapeutics names Kyra Peckaitis VP of marketing By Investing.com - Investing.com Canada
Dermata Therapeutics names Kyra Peckaitis VP of marketing - Investing.com Nigeria
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - Nasdaq
Retail Surge: Is Dermata Therapeutics Inc Equity Warrant a strong candidate for buy and holdJuly 2025 Short Interest & Accurate Intraday Trading Signals - baoquankhu1.vn
Exit Recap: Is Dermata Therapeutics Inc a momentum stockMarket Volume Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Dermata Therapeutics Launches Tome Skincare Line to Address Daily Skin Health Needs - geneonline.com
Dermata Opens a New Chapter with the Release of Tome Skincare - standard-journal.com
Once‑weekly acne treatment at home: Dermata’s new Tome skincare line - Stock Titan
DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Wall Street Zen Upgrades Dermata Therapeutics (NASDAQ:DRMA) to Hold - Defense World
Dermata Therapeutics Announces Board Resignation and Size Reduction - TipRanks
Board shakeup at Dermata (DRMA) as director Mary Fisher plans exit - Stock Titan
ARMISTICE CAPITAL, LLC Reduces Stake in Dermata Therapeutics Inc - GuruFocus
Update Report: Will Dermata Therapeutics Inc benefit from seasonalityPortfolio Performance Report & Weekly Return Optimization Alerts - baoquankhu1.vn
DRMAW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Large Dermata (DRMA) holder Gerald Proehl reports 17.3% ownership stake - Stock Titan
Growth Value: What is Dermata Therapeutics Incs valuation compared to sector2025 Winners & Losers & Technical Pattern Alert System - baoquankhu1.vn
Contrasting Qiagen (NYSE:QGEN) & Dermata Therapeutics (NASDAQ:DRMA) - Defense World
Chipmakers Recap: Can Dermata Therapeutics Inc Equity Warrant grow without external fundingJuly 2025 Rallies & Daily Risk Controlled Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Growth Recap: Is Dermata Therapeutics Inc Equity Warrant benefiting from innovation trendsQuarterly Growth Report & Low Drawdown Trading Techniques - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Market Movers | Winners: ADVB, KNRX, DRMA | Losers: MBRX, ALIT, DBGI - Trefis
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Armistice Capital, Steven Boyd disclose 4.99% stake in Dermata (DRMA) - Stock Titan
ACXP PE Ratio & Valuation, Is ACXP Overvalued - Intellectia AI
Can Dermata Therapeutics Inc. expand into new markets2025 AllTime Highs & Verified Technical Trade Signals - mfd.ru
Can Dermata Therapeutics Inc. Equity Warrant stock double in the next yearWeekly Market Summary & AI Powered Market Trend Analysis - mfd.ru
How rising interest rates impact Dermata Therapeutics Inc. stockJuly 2025 Chart Watch & Verified Stock Trade Ideas - mfd.ru
HSDT PE Ratio & Valuation, Is HSDT Overvalued - Intellectia AI
DRMA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Bristol Investment Fund Ltd. v. Dermata Therapeutics Inc.: Complaint (‘$160K Breach of Contract’) - OffshoreAlert
Bull Run: Can AVITA Medical Inc weather a recessionMarket Performance Summary & Precise Buy Zone Identification - baoquankhu1.vn
Will Dermata Therapeutics Inc. stock benefit from AI adoption2025 Momentum Check & AI Forecasted Entry/Exit Points - mfd.ru
Stock Report: Should I average down on Dermata Therapeutics Inc Equity Warrant stockJuly 2025 Short Interest & Real-Time Buy Signal Notifications - baoquankhu1.vn
Surprises Report: What are Twin Hospitality Group Incs technical support levels - baoquankhu1.vn
Is Dermata Therapeutics Inc a momentum stockTrade Volume Report & Long-Term Investment Growth Plans - baoquankhu1.vn
Aug Opening: What are the future prospects of iSpecimen Inc2025 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Aug Weekly: Is Eureka Acquisition Corp Debt Equity Composite Units a cyclical or defensive stockGold Moves & Fast Moving Trade Plans - baoquankhu1.vn
Will Dermata Therapeutics Inc. Equity Warrant stock outperform Nasdaq indexJuly 2025 Update & Entry Point Confirmation Signals - mfd.ru
Loss Report: Is Dermata Therapeutics Inc Equity Warrant stock risky to hold nowWeekly Gains Summary & Verified Entry Point Detection - baoquankhu1.vn
History Review: Can ALUR disrupt its industryJuly 2025 Macro Moves & Growth Focused Stock Reports - baoquankhu1.vn
What is Dermata Therapeutics Inc.’s valuation compared to sectorJuly 2025 Spike Watch & Target Return Focused Picks - mfd.ru
Tuesday's after hours session: top gainers and losers - Chartmill
Meme Stocks: Is NRx Pharmaceuticals Inc Equity Warrant forming a breakout pattern2025 Market Overview & Expert Curated Trade Setups - baoquankhu1.vn
Dermata Therapeutics increases at-the-market offering by $705,000 - Investing.com Nigeria
Dermata Therapeutics increases at-the-market offering by $705,000 By Investing.com - Investing.com South Africa
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity - TipRanks
Market Movers | Winners: GRI, XXII, LRHC | Losers: NBY, EMAT, APUS - Trefis
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Gap Down: Why is AHLPRF stock going downMarket Activity Report & Accurate Intraday Trade Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Whats next for M3 Brigade Acquisition V Corp stockJuly 2025 Spike Watch & Precise Buy Zone Identification - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Aug Momentum: Does RRGB meet Warren Buffetts criteriaMarket Trend Summary & Precise Swing Trade Alerts - baoquankhu1.vn
Dermata receives Australian patent for Spongilla acne treatment By Investing.com - Investing.com Nigeria
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):